IL-12 is mainly produced by DCs in response to tumor-associated antigens or during the release of damage-associated molecular patterns (DAMPs) such as HMGB1, HSP, and calreticulin in the tumor microenvironment [3]. The gene discussed is HMGB1; the disease is neoplasm.